Search results
Results From The WOW.Com Content Network
Cannabis in New York has been legal for medical purposes under New York law since 2016, and recreational purposes since 2021. As of 2022, recreational cannabis is for sale legally in the state (including Native American reservations), only through state-approved dispensaries.
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]
Notes: · Reflects laws of states and territories, including laws which have not yet gone into effect. Does not reflect federal, tribal, or local laws. · Map does not show state legality of hemp-derived cannabinoids such as CBD or delta-8-THC, which have been legal at federal level since enactment of the 2018 Farm Bill
New York officials launched legal recreational marijuana sales by promising many of the first retail licenses to people with past drug convictions, hoping to give people harmed by the war on drugs ...
David Robinson, New York State Team June 14, 2024 at 12:20 AM New York regulators approved home grown cannabis rules this week, allowing adult New Yorkers to now possess up to 12 cannabis plants ...
Notes: · Reflects laws of states and territories, including laws which have not yet gone into effect. Does not reflect federal, tribal, or local laws. · Map does not show state legality of hemp-derived cannabinoids such as CBD or delta-8-THC, which have been legal at federal level since enactment of the 2018 Farm Bill
Marijuana plants for the adult recreational market are are seen in a greenhouse at Hepworth Farms in Milton, N.Y., July 15, 2022. New York has issued the first 36 cannabis dispensary licenses on ...
The law also expands the state's existing medical marijuana program, allowing doctors greater discretion to prescribe cannabis to patients without needing to cite a specific state-defined qualifying condition. Tax revenue under the act for the City of New York was estimated by the state comptroller in 2017 to be at least $400 million annually. [19]